Netball Victoria and the Melbourne Vixens are proud to announce a new partnership with Bupa.
The new partnership, commencing at the start of the 2018 season, will see Bupa become the naming rights sponsor for the Victorian Netball League (VNL) for the next three years.
As one of Australia’s leading health and care companies, the commitment Bupa has shown to netball across the state at a grassroots level will allow the development and continued pathway for talented female athletes.
The Bupa VNL has been the premier netball competition in Victoria since its induction in 2009. It is currently made up of 10 teams which play across three tiers of competition – Championship, Division 1 and 19 and Under.
Netball Victoria Chief Executive Officer, Rosie King said Bupa joining the Netball Victoria family is an exciting opportunity for our sport.
“It’s great to partner with a company that is so committed to developing female sport from a grassroots level,” said Ms King.
“This will also provide a significant benefit and support to the many female athletes currently involved in the talent pathways.”
Bupa Australia’s Lucy Coggan said the new partnership strongly aligns with Bupa’s commitment to helping people live longer, healthier, happier lives.
“We’re excited to be partnering with Netball Victoria, an organisation that plays an integral role in encouraging fitness and sport participation in young people, especially girls and women,” she said.
“Netball is a great activity for the whole family to enjoy together. By supporting elite and grassroots netball we can encourage families to spend quality time together, to keep active and to connect over a sport they love.”
The 2018 Bupa VNL season begins on Sunday 29 April at the State Netball & Hockey Centre.
Bupa Australia is committed to improving the health of the Australian community and ensuring the sustainability of affordable healthcare.
Over the past decade Bupa has invested close to $30million in projects that aim to improve health outcomes for the Australian community.
Bupa is part of a global family that reinvests its profits into keeping healthcare and health cover affordable, as well as supporting pioneering health research and community programs.